Impact of Coffeeberry Extract on Skill Performance During Simulated Match Play in Academy Football Players

NCT ID: NCT05547204

Last Updated: 2023-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-30

Study Completion Date

2022-12-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study of soccer skill performance has three objectives:

1. Compare effects of coffeeberry (300mg) and placebo ingestion on dribbling speed and precision, passing speed and accuracy, and sprint speed during a full simulated soccer match.
2. Compare effects of coffeeberry (300mg) and placebo ingestion on subjective measures (mental / physical energy and activation-deactivation (feelings or mood) during a full simulated soccer match.
3. Compare effects of coffeeberry (300mg) and placebo ingestion on chlorogenic acid (CGA) and caffeine metabolites in the blood 1-hour post ingestion, and other blood metabolites (glucose/lactate) throughout the simulated soccer match.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skill Performance Soccer Performance Coffeeberry Effects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coffeeberry beverage

300 ml drink containing 300 mg coffeeberry extract

Group Type EXPERIMENTAL

Beverage

Intervention Type OTHER

Free from added carbohydrates (contain 1g CHO only) and electrolytes are absent.

Color and flavor matched beverage

300 ml drink (0 mg coffeeberry extract, 0 mg caffeine)

Group Type PLACEBO_COMPARATOR

Beverage

Intervention Type OTHER

Free from added carbohydrates (contain 1g CHO only) and electrolytes are absent.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Beverage

Free from added carbohydrates (contain 1g CHO only) and electrolytes are absent.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provide valid informed consent prior to any study procedure
* Male soccer players age 16 to 28 years.
* \>= 5-year soccer playing experience
* \>= 1-year regularly soccer training
* Free of injuries
* Willing to avoid alcohol in the 48-h period prior to all visits
* Willing to avoid caffeinated products and apples, berries/cherries for 24-h prior to all visits
* Willing to record food intake over the 48-h period prior to the first trial and replicate for second trial
* Willing to abstain from strenuous physical activity for 24-h before all visits

Exclusion Criteria

* Smoking
* Cardiovascular diseases
* Diabetes or other metabolic disease • Hypertension (\>140/\>90 mm Hg)
* Presence of injuries
* Major illnesses or surgery in prior 90 days
* Participation in another clinical trial in the past month
Minimum Eligible Age

16 Years

Maximum Eligible Age

28 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PepsiCo Global R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stuart Galloway, PhD

Role: PRINCIPAL_INVESTIGATOR

U. Stirling, Scotland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

U. Stirling, Health Science and Sport

Stirling, Scotland, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEP-2114

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Caffeine's Effect on Attention
NCT02264561 COMPLETED NA